Dynamic Technology Lab Private LTD Aerie Pharmaceuticals Inc Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.64 - $9.8 $338,997 - $589,038	-60,106 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.02 - $13.33 $421,944 - $801,212	60,106 New	60,106 $422,000
Q2 2021 Aug 13, 2021	SELL	$15.16 - $18.97 $193,123 - $241,658	-12,739 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$13.12 - $20.9 $167,135 - $266,245	12,739 New	12,739 $228,000
Q3 2019 Nov 14, 2019	SELL	$18.41 - $28.0 $307,667 - $467,936	-16,712 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $484,146 - $805,685	16,712 New	16,712 $494,000
Q3 2017 Nov 08, 2017	SELL	$48.6 - $60.1 $386,710 - $478,215	-7,957 Closed	0 $0
Q2 2017 Aug 17, 2017	BUY	N/A	7,957	7,957 $418,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.